Hospital
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals was paid $10.83M by Medicaid between Jan 2018 and Dec 2024, across 232 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoKAISER FOUNDATION HOSPITALS
SANTA ROSA, CA 95403
SANTA ROSA, CA 95403
33aNPI1407925928assigned 11/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.83M
24GClaims818,556
24DCodes billed232
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#174 of 410
Median peer was paid$6.90M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,508 | $419K | |
| 2019 | 83,470 | $472K | |
| 2020 | 86,392 | $530K | |
| 2021 | 132,546 | $595K | |
| 2022 | 164,973 | $747K | |
| 2023 | 174,528 | $825K | |
| 2024incomplete | 120,139 | $7.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 21,165 | 18,999 | $2.25M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 7,963 | 7,453 | $1.43M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12% | 17,502 | 16,668 | $1.34M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 11% | 23,579 | 21,288 | $1.15M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.2% | 4,692 | 4,589 | $562K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.7% | 8,670 | 8,204 | $402K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.9% | 1,999 | 1,887 | $313K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 4,018 | 3,903 | $221K |
| 71046 | Radiologic examination, chest; 2 views | 1.9% | 9,335 | 9,085 | $204K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.3% | 3,884 | 3,500 | $143K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 8,418 | 7,869 | $126K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.0% | 1,562 | 1,542 | $112K |
220 more codes
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.0% | 4,042 | $112K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,479 | $91K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 48,776 | $88K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,289 | $86K |
| 76830 | Ultrasound, transvaginal | <1% | 2,969 | $82K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,291 | $80K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,051 | $78K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,593 | $73K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,867 | $66K |
| 73610 | <1% | 2,742 | $56K | |
| 80051 | <1% | 28,048 | $53K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,799 | $53K |
| 73630 | <1% | 2,790 | $49K | |
| G0378 | Hospital observation service, per hour | <1% | 364 | $44K |
| 82565 | <1% | 39,163 | $43K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,261 | $42K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,033 | $39K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,013 | $39K |
| 93971 | <1% | 922 | $39K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,891 | $38K |
| 73030 | <1% | 2,070 | $38K | |
| 73130 | <1% | 2,221 | $38K | |
| 73110 | <1% | 2,053 | $37K | |
| 72100 | <1% | 1,803 | $36K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,252 | $35K |
| 73560 | <1% | 2,027 | $34K | |
| 83880 | <1% | 5,102 | $34K | |
| J3490 | Unclassified drugs | <1% | 13,976 | $34K |
| 80306 | <1% | 3,921 | $33K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 122 | $30K |
| 82947 | <1% | 29,328 | $29K | |
| 73564 | <1% | 1,132 | $28K | |
| 76770 | <1% | 786 | $28K | |
| 86900 | <1% | 3,368 | $27K | |
| 84520 | <1% | 28,628 | $27K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,946 | $27K |
| 83690 | <1% | 14,719 | $26K | |
| 82247 | <1% | 23,950 | $25K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 387 | $24K |
| 84460 | <1% | 26,344 | $24K | |
| 82077 | <1% | 3,737 | $23K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 333 | $22K |
| 87631 | <1% | 542 | $22K | |
| 73140 | <1% | 1,224 | $21K | |
| 84450 | <1% | 21,121 | $20K | |
| 74018 | <1% | 1,290 | $20K | |
| 99070 | <1% | 9,029 | $19K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,456 | $19K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,650 | $18K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,646 | $18K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,553 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,260 | $17K |
| 84484 | <1% | 6,861 | $17K | |
| 81001 | <1% | 27,241 | $16K | |
| 84075 | <1% | 17,453 | $16K | |
| 83735 | <1% | 9,177 | $15K | |
| 72040 | <1% | 1,045 | $14K | |
| 87040 | <1% | 3,072 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,530 | $13K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,394 | $13K |
| 93976 | <1% | 470 | $12K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,142 | $12K |
| 86850 | <1% | 2,723 | $12K | |
| 83605 | <1% | 4,013 | $12K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,165 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 133 | $11K |
| 73080 | <1% | 929 | $11K | |
| 80179 | <1% | 1,736 | $11K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,052 | $10K |
| 84702 | <1% | 4,591 | $10K | |
| 87088 | <1% | 5,575 | $10K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 58 | $10K |
| 73502 | <1% | 810 | $9K | |
| 86901 | <1% | 3,371 | $9K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,271 | $9K |
| 84100 | <1% | 6,300 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,178 | $7K |
| 85610 | <1% | 8,653 | $7K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,898 | $7K |
| 81003 | <1% | 16,218 | $7K | |
| 85652 | <1% | 11,214 | $6K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 58 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,978 | $5K |
| 76870 | <1% | 287 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,742 | $5K |
| 74022 | <1% | 404 | $5K | |
| 85027 | <1% | 5,457 | $5K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,129 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,709 | $4K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 181 | $4K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,904 | $4K |
| 82248 | <1% | 3,125 | $4K | |
| 70486 | <1% | 144 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 155 | $4K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,580 | $4K |
| 85379 | <1% | 2,023 | $3K | |
| 87324 | <1% | 1,371 | $3K | |
| 87449 | <1% | 1,376 | $3K | |
| 73590 | <1% | 110 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 153 | $3K |
| 0450 | Emergency room services | <1% | 73 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,101 | $3K |
| 82310 | <1% | 4,028 | $3K | |
| 86140 | <1% | 2,314 | $3K | |
| 82962 | <1% | 3,448 | $3K | |
| 71250 | <1% | 127 | $3K | |
| 82570 | <1% | 1,208 | $2K | |
| 82040 | <1% | 3,082 | $2K | |
| 84132 | <1% | 5,351 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,182 | $2K |
| 84703 | <1% | 7,082 | $2K | |
| 86780 | <1% | 1,512 | $2K | |
| 85730 | <1% | 1,479 | $2K | |
| 73090 | <1% | 101 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 722 | $2K |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 718 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,582 | $2K |
| 85378 | <1% | 918 | $2K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 247 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,085 | $2K |
| 87070 | <1% | 783 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,447 | $2K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,378 | $1K |
| 71101 | <1% | 26 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 235 | $1K |
| 86803 | <1% | 1,350 | $1K | |
| 0270 | <1% | 266 | $1K | |
| 87340 | <1% | 1,307 | $1K | |
| 80061 | Lipid panel | <1% | 2,744 | $1K |
| 84156 | <1% | 976 | $1K | |
| 59025 | Fetal non-stress test | <1% | 251 | $1K |
| 0637 | <1% | 8,133 | $1K | |
| 82803 | <1% | 154 | $1K | |
| J1815 | Injection, insulin, per 5 units | <1% | 691 | $921.45 |
| 84439 | <1% | 907 | $878.09 | |
| 76536 | <1% | 103 | $861.35 | |
| 82728 | <1% | 1,397 | $857.66 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 85 | $785.41 |
| 82550 | <1% | 450 | $777.08 | |
| 85007 | <1% | 793 | $771.38 | |
| 84295 | <1% | 3,136 | $765.81 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 311 | $559.28 |
| 87506 | <1% | 12 | $483.90 | |
| 82150 | <1% | 356 | $456.19 | |
| 96376 | <1% | 170 | $422.82 | |
| 83615 | <1% | 572 | $414.20 | |
| 86706 | <1% | 238 | $410.93 | |
| 88304 | <1% | 538 | $356.70 | |
| 72141 | <1% | 12 | $314.93 | |
| 0250 | <1% | 639 | $287.03 | |
| 90715 | <1% | 28 | $285.90 | |
| 83540 | <1% | 927 | $223.08 | |
| 84550 | <1% | 487 | $214.87 | |
| 83550 | <1% | 745 | $210.61 | |
| 90686 | <1% | 79 | $199.68 | |
| 88342 | <1% | 297 | $195.86 | |
| 72070 | <1% | 12 | $186.04 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 112 | $168.66 |
| 74019 | <1% | 54 | $163.18 | |
| 80069 | <1% | 181 | $162.93 | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 67 | $157.75 |
| 73660 | <1% | 54 | $155.92 | |
| 80053 | Comprehensive metabolic panel | <1% | 401 | $143.00 |
| Z7502 | <1% | 12 | $136.40 | |
| 87081 | <1% | 83 | $133.18 | |
| 86704 | <1% | 40 | $127.71 | |
| 73522 | <1% | 12 | $121.41 | |
| 85014 | <1% | 171 | $117.80 | |
| 88307 | <1% | 217 | $113.95 | |
| 73100 | <1% | 13 | $106.45 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 90 | $106.17 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 433 | $106.05 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 136 | $105.38 |
| 83516 | <1% | 27 | $89.44 | |
| 82140 | <1% | 28 | $84.20 | |
| 82043 | <1% | 332 | $63.69 | |
| 82607 | <1% | 524 | $57.32 | |
| 82784 | <1% | 13 | $56.69 | |
| J8501 | Aprepitant, oral, 5 mg | <1% | 80 | $52.20 |
| 87205 | <1% | 215 | $49.36 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 14 | $47.37 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 74 | $42.84 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 40 | $41.32 |
| 80047 | <1% | 13 | $29.74 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 12 | $26.92 |
| 85008 | <1% | 191 | $26.03 | |
| G0151 | Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes | <1% | 2,000 | $25.82 |
| 82272 | <1% | 96 | $23.31 | |
| 85018 | <1% | 199 | $23.05 | |
| 84155 | <1% | 90 | $22.86 | |
| 89051 | <1% | 29 | $12.64 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 369 | $8.84 |
| 85045 | <1% | 74 | $8.77 | |
| 82435 | <1% | 70 | $3.00 | |
| 82374 | <1% | 75 | $3.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 13 | $0.00 |
| 88341 | 0% | 12 | $0.00 | |
| G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | 0% | 620 | $0.00 |
| 86762 | 0% | 13 | $0.00 | |
| 84153 | 0% | 94 | $0.00 | |
| G0152 | Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes | 0% | 98 | $0.00 |
| 80349 | 0% | 39 | $0.00 | |
| 12001 | 0% | 12 | $0.00 | |
| 70491 | 0% | 16 | $0.00 | |
| Q5001 | Hospice or home health care provided in patient's home/residence | 0% | 34 | $0.00 |
| 86664 | 0% | 13 | $0.00 | |
| 90999 | Dialysis (unlisted procedure) | 0% | 11,646 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 787 | $0.00 |
| 76376 | 0% | 180 | $0.00 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 49 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 278 | $0.00 |
| 83970 | 0% | 91 | $0.00 | |
| 84466 | 0% | 22 | $0.00 | |
| 84403 | 0% | 26 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 30 | $0.00 |
| 81025 | 0% | 66 | $0.00 | |
| 76642 | 0% | 30 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 20 | $0.00 |
| 90756 | 0% | 13 | $0.00 | |
| 86665 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOFFEY, JUDITH (SENIOR VICE PRESIDENT, AREA MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Kaiser Foundation Hospitals | Santa Rosa, CA | $237K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.